Prelude Therapeutics
PRLD
$3.91
Share price
-0.51%
Change (1 day)
-29.68%
Change (1 year)
Categories
Earnings for Prelude Therapeutics (PRLD)
Earnings in 2023 (TTM): -$0.14 B
According to Prelude Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.14 B. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Prelude Therapeutics from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.14 B | 7.07% |
| 2022 | -$0.13 B | 8.62% |
| 2021 | -$0.12 B | 93.55% |
| 2020 | -$58.77 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -17.03% | 🇺🇸 USA |